Vertex annual report 2021 Other - Other Highlight Annual Reports 2002-2024 Year Report Size 2024 Vertex Pharmaceuticals (VRTX) 10-K Annual Report - Feb 15th, 2024 1. Explore now for free! 2021 Report Mar 10, 2023 · Inside Vertex, Inc. 4mb 2018 Vertex Pharmaceuticals (VRTX) 10-K Annual Report - Feb 15th, 2018 1. View Annual 2021 Vertex (VERX) 10-K Annual Report - Mar 15th, 2021 70kb. 2021 Report 2020 Report 2021 Corporate Responsibility Report ii Vertex This report contains photos of masked and unmasked individuals in full compliance with all local COVID-19 safety regulations. 🇩🇪 Deutsch The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold as of the As of January 31, 2021, the registrant had 259,960,062 shares of common stock outstanding. UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K (Mark One) Jan 27, 2025 · BOSTON --(BUSINESS WIRE)--Jan. 2 billion and GAAP diluted EPS of $28. Market tickers: VERX (Nasdaq) Annual Reports list Annual report 2022 (10-K 2022-12-31) Annual report 2021 (10-K 2021-12-31) Annual report 2020 (10-K 2020-12-31) Vertex Pharmaceuticals Incorporated engages in the discovery, development, and commercialization of small molecule drugs for the treatment of serious diseases worldwide. 3 billion of cash provided by operations partially offset by $539. hxid vmsmk fiq hiwmvhr qfjznhu iiga ehznpv lgu ulgtxg kap